Yingqi Shi

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease

Reisa A. Sperling, David Henley, Paul Aisen et al. · JAMA Neurology · 2021 · 110 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

A β‐ketoacyl carrier protein reductase confers heat tolerance via the regulation of fatty acid biosynthesis and stress signaling in rice

Fei Chen, Guojun Dong, Fang Wang et al. · New Phytologist · 2021 · 72 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

Mahesh N. Samtani, Nandini Raghavan, Yingqi Shi et al. · British Journal of Clinical Pharmacology · 2012 · 51 citations · Full text

Medicine, Neurology, Neuroscience +17

Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms

James Fidelholtz, William Smith, James Rawls et al. · The American Journal of Gastroenterology · 2002 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +16

MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab + Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Elena Zamagni, Mario Boccadoro, Andrew Spencer et al. · Blood · 2022 · 29 citations

Medicine, Oncology, Pharmacotherapy +14